Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy
Not Applicable
Recruiting
- Conditions
- Malignant Breast Neoplasm
- Interventions
- Radiation: Standard RadiationRadiation: Ultra-hypofractionated whole breast radiotherapy
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 36
- Registration Number
- NCT05665920
- Locations
- 🇧🇷
IBCC Oncologia, Sao Paulo, SP, Brazil
Transgender Observational Performance
- Conditions
- Transgender Persons
- Interventions
- Other: Aerobic exercise test.
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 60
- Registration Number
- NCT05337865
Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia
- Conditions
- Breast Neoplasm
- Interventions
- Other: ctDNA level during neoadjuvant chemotherapy
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 38
- Registration Number
- NCT05050890
- Locations
- 🇧🇷
IBCC Oncologia, Sao Paulo, SP, Brazil
Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Quality of life in Breast Cancer Survivors
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 105
- Registration Number
- NCT04834570
- Locations
- 🇧🇷
IBCC Oncologia, São Paulo, Brazil
Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 54
- Registration Number
- NCT04833998
- Locations
- 🇧🇷
IBCC Oncologia, São Paulo, Brazil
Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy
- Conditions
- Chemotherapy-induced Nausea and Vomiting
- Interventions
- Other: Quality-of-life assessment
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 50
- Registration Number
- NCT04785495
- Locations
- 🇧🇷
Rafaela de Brito Alves, São Paulo, SP, Brazil
Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
Phase 2
- Conditions
- Sinusoidal Obstruction Syndrome (SOS)Hematopoietic Stem Cell Transplant (HSCT)
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 80
- Registration Number
- NCT04712435
- Locations
- 🇧🇷
Jamilla Neves Cavalcante, Sao Paulo, SP, Brazil
Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery
Not Applicable
Recruiting
- Conditions
- Malignant Neoplasm of Breast
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 36
- Registration Number
- NCT04669873
- Locations
- 🇧🇷
IBCC Oncologia, Sao Paulo, SP, Brazil
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer
Phase 2
Completed
- Conditions
- Nausea Post Chemotherapy
- Interventions
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 50
- Registration Number
- NCT04669132
- Locations
- 🇧🇷
IBCC Oncologia, São Paulo, Brazil
Prehabilitation Plus ERAS Versus ERAS in Gynecologic Oncology: a Randomized Clinical Trial
Phase 3
Recruiting
- Conditions
- Gynecologic CancerEnhanced Recovery After Surgery
- Interventions
- Other: Enhanced Recovery After SurgeryOther: Prehabilitation Program + Enhanced Recovery After Surgery
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Instituto Brasileiro de Controle do Cancer
- Target Recruit Count
- 194
- Registration Number
- NCT04596800
- Locations
- 🇧🇷
Instituto Brasileiro de Controle do Cancer - IBCC, Sao Paulo, Brazil
© Copyright 2025. All Rights Reserved by MedPath